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ABSTRACT 
Rhodopsin is the visual photoreceptor of the retinal rod cells that mediates dim light 
vision and a prototypical member of the G protein-coupled receptor superfamily. The 
structural stability and functional performance of rhodopsin are modulated by membrane 
lipids. Docosahexaenoic acid has been shown to interact with native rhodopsin but no 
direct evidence has been established on the effect of such lipid on the stability and 
regeneration of rhodopsin mutants associated with retinal diseases. The stability and 
regeneration of two thermosensitive mutants G90V and N55K, associated with the retinal 
degenerative disease retinitis pigmentosa, have been analyzed in docosohexaenoic 
phospholipid (1,2-didocosa-hexaenoyl-sn-glycero-3-phosphocholine; DDHA-PC) 
liposomes. G90V mutant reconstituted in DDHA-PC liposomes significantly increased 
its thermal stability, but N55K mutant showed similar thermal sensitivity both in dodecyl 
maltoside detergent solution and in DDHA-PC liposomes. The retinal release process, 
measured by fluorescence spectroscopy, became faster in the lipid system for the two 
mutants. The opsin conformation was stabilized for the G90V mutant allowing improved 
retinal uptake whereas no chromophore binding could be detected for N55K opsin after 
photoactivation. The results emphasize the distinct role of DHA on different phenotypic 
rhodopsin mutations associated with classical (G90V) and sector (N55K) retinitis 
pigmentosa.  
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Introduction 
G protein-coupled receptors (GPCRs) constitute one of the largest protein families in the 
mammalian genome.
1
 A wide range of different external stimuli are known to activate 
GPCRs, like ions, organic odorants, amines, peptides, proteins, lipids, nucleotides and 
photons enabling signal transduction to the interior of the cell.
2,3
 Considering their roles 
in cell signal transduction, GPCRs are main targets for drug development towards a 
number of pathological conditions. GPCRs are grouped into six families with the 
rhodopsin (Rho)-like family (Class A) as the largest subfamily of receptors.
4
 The visual 
photoreceptor Rho is a prototypical member for Class A GPCRs superfamily. Rho 
consists of a seven-helical transmembrane opsin apoprotein and an 11-cis-retinal 
chromophore, linked to K296 of the protein via a protonated Schiff Base (SB) linkage.
5,6
 
The atomic structure of the inactive dark state of Rho and other relevant conformational 
states have been determined by X-ray crystallography.
7,8
 Upon photon absorption, 
11-cis-retinal isomerizes to all-trans-retinal and triggers receptor activation by means of 
conformational rearrangements leading to the active metarhodopsin II (Meta II) 
conformation that initiates G-protein signal transduction.
6,9,10
 
Retinitis pigmentosa (RP) is a diverse group of eye disorders causing retinal degeneration 
and leading to blindness.
11,12
 RP associated with mutations in Rho is proposed as mainly a 
protein-misfolding disease caused by heterogeneous mutations which modify the cellular 
fate and induce photoreceptor cell death.
13–15
 In addition to protein misfolding, other 
molecular mechanisms for RP, like retinal regeneration alterations and thermal instability 
have been proposed.
12,16,17
 Typically, Rho mutants are purified in the mild neutral 
detergent n-Dodecyl-β-D-maltoside (DM) which may accentuate this structural 
instability.
18
 To protect the membrane protein stability and function, a 
physiologically-relevant lipid bilayer environment was used.
19–22
 Herein, 
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1,2-didocosa-hexaenoyl-sn-glycero-3-phosphocholine (DDHA-PC (22:6n-3)), formed 
by two DHA chains, was used to study the effect of this lipid on Rho mutant 
conformation and stability. DHA accounts for 50-60% of the total fatty acids in the retina 
and optimizes retinal integrity and visual function.
23–26
 Compared with other 
phosphorylated lipids, such as saturated, long chain (14:0) DMPC, DMPG and 
DMPS,
27–29
 DDHA-PC is unsaturated and highly specific to the retina and can modulate 
Rho stability and function.
22,24,30
 We have previously demonstrated the specific role of 
DHA phspholipid in increasing native Rho thermal stability.
24
 Therefore, the study of 
Rho mutants in DDHA-PC liposomes is a more appropriate system to reveal novel clues 
for understanding the degeneration mechanisms of RP in a native environment. To this 
aim, we have analyzed the conformational properties of the highly unstable G90V and 
N55K mutants associated with classical and sector RP, respectively.
31,32
 
We have found that purified G90V and N55K mutants can be successfully reconstituted 
in DDHA-PC liposomes but the conformational properties of the two mutants are 
completely different. In the case of G90V, the lipid environment increased the thermal 
stability in the dark and improved opsin conformational stability allowing efficient ligand 
binding and chromophore regeneration after complete Meta II decay. DDHA-PC 
liposomes also speeded up the retinal release process. In the case of N55K, neither 
obvious thermal stability enhancement nor retinal entrance after Meta II decay in 
DDHA-PC liposomes were observed. The only feature that was shared with the G90V 
mutant was an accelerated retinal release rate after illumination. These results confirm the 
diverse effect of DDHA-PC on Rho mutants and highlight the different response of 
classical RP and sector RP mutants to the specific lipid environment depending on the 
conformational properties of these distinct mutations. 
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Experimental procedures 
Materials 
G90V and N55K opsin genes were cloned into the pMT4 plasmid. 11-cis-retinal 
chromophore was kindly provided from Dr. R. Crouch and the National Eye Institute, 
National Institutes of Health (USA). DDHA-PC (22:6n-3) was purchased from Avanti 
Polar Lipids Inc (Alabaster, AL). DM was from Anatrace (Maumee, OH, USA). 
Chloroform was purchased from Sigma-Aldrich (Sant Louis, MO), methanol was from 
Panreac (Barcelona, Spain) and the polystyrene beads (Bio-beads SM-2) used for DM 
removal were provided by Bio-Rad Laboratories, Inc. (Hercules, CA).  
Polyethyleneimine 25 kDa (PEI) was purchased from Polysciences (Warrington, PA, 
USA). Purified mAb rho-1D4 was purchased from Cell Essentials (Boston, MA USA) 
and coupled to CNBr-activated Sepharose 4B Fast Flow (Amersham Biosciences). The 
1D4 9-mer peptide H-TETSQVAPA-OH was synthesized by Unitat de Tecniques 
Separatives i Sintesi de Peptids (Universitat de Barcelona, Spain). Hydroxylamine, 
protease inhibitor cocktail and phenylmethanesulfonyl (PMSF) were from Sigma-Aldrich 
(St. Louis, MO, USA).  
Buffers 
The following buffers were used: PBS: 137 mM NaCl, 2.7 mM KCl, 1.5 mM KH2PO4, 
and 8 mM Na2HPO4, pH 7.4; washing buffer: PBS containing 0.05% DM. 
Cell culture materials 
COS-1 cells were purchased from the American Type Culture Collection (Manassas, 
VA, USA), DMEM, fetal bovine serum, L-glutamine and antibiotics 
penicillin-streptomycin were from Sigma-Aldrich (St. Louis, MO, USA), OPTIMEM 
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reduced Serum Media for DNA transfection was from Life Technologies (Madrid, 
Spain).  
Methods 
Expression and purification of Rho WT and G90V, N55K mutants 
Bovine recombinant wild type (WT) Rho, and the G90V and N55K mutants genes were 
constructed in the pMT4 plasmid vectors by site-directed mutagenesis.
33
 Plasmids were 
transfected into five COS-1 cell plates, at 85% confluence, by using PEI with 30 µg of 
plasmid DNA per 145 cm plate. After 48 h, cells were harvested and regenerated with 10 
µM 11-cis-retinal in PBS by overnight incubation. Cells solubilization was carried out 
by 1 h incubation with 1% (w/v) DM, 100 µM PMSF and protease inhibitors at 4ºC, 
followed by ultracentrifugation at 30,000 rpm for 30 min (in a Ti50 rotor). The 
supernatants obtained were used for immunoaffinity chromatography purification by 
means of Rho-1D4 antibody coupled to sepharose beads to a final concentration of 52.5 
µg/ml. After 3 h incubation, the Rho-1D4-sepharose-bound WT or mutants were eluted 
with PBS containing 0.05% DM and 100  M 1D4 9-mer peptide.18 The protein was 
immediately used or stored at -80°C.  
Preparation of DDHA-PC proteoliposomes 
DDHA-PC powder was dissolved in chloroform: methanol (2:1, v/v) and the solution was 
evaporated to dryness under a stream of nitrogen until no solvent trace was detected. The 
lipid film was hydrated with PBS pH 7.4 to obtain the liposomes. The liposomes were 
mixed with 0.5% DM and the solubilized protein was subject to gentle agitation for 30 
min at 4°C. Bio-beads SM-2 were added to extract the extra DM.
34
 Finally, the 
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proteoliposomes system consisted of 1.05 mM DDHA-PC liposomes and 1.4 µM WT or 
mutants (750:1 molar ratio). 
Ultraviolet-visible (UV-Vis) absorption spectra of WT, G90V and N55K 
All the measurements were carried out in a Cary 100Bio spectrophotometer (Varian, 
Australia), equipped with water-jacketed cuvette holders connected to a circulating 
water bath. A Peltier accessory connected to the spectrophotometer was used to control 
the temperature. All spectra were recorded in the 250 nm-650 nm range with a 
bandwidth of 2 mm, a response time of 0.1 s, and a scan speed of 300 nm/min.  
Thermal bleaching assay by UV-Vis spectroscopy 
UV-Vis spectroscopy was used to follow WT and mutants thermal stability. WT and 
mutants thermal bleaching rates were obtained, in the dark, by monitoring the decrease of 
the maximum absorbance value in the visible spectral band (λmax) over time at 48°C. 
Spectra were recorded every min. Data points were obtained by using the equation 
                 , where A is the absorbance at λmax, Af is the absorbance at the 
final time, and A0 is the absorbance at time 0. The half-life time (t1/2) for the process was 
determined by fitting the experimental data to single exponential decay curves using 
Sigma Plot version 11.0 (Systat Software, Chicago, IL, USA). Experiments were 
performed at least three times using independently purified samples. 
Retinal release kinetics and opsin conformational stability by fluorescence 
spectroscopy 
Fluorescence spectroscopic measurements were carried out with a Photon Technologies 
QM-1 steady-state fluorescence spectrophotometer (PTI Technologies, Birmingham, 
NJ, USA). The sample temperature was controlled with a cuvette holder Peltier 
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accessory TLC 50 (Quantum Northwest, Liberty Lake, WA, USA) connected to a 
hybrid liquid coolant system Reserator XT (Zalman, Garden Grove, CA, USA). 
Upon illumination, the chromophore undergoes isomerization from 11-cis to all-trans 
configuration with subsequent formation of the active Meta II conformation. Under our 
experimental conditions, the Meta II decay parallels the retinal release process. Thus, 
Meta II decay is followed by the Trp fluorescence increase at 330 nm due to the retinal 
release from the opsin apoprotein. Fluorescence was monitored over time with an 
excitation wavelength of 295 nm and an emission wavelength of 330 nm. All 
fluorescence spectra were carried out by exciting the samples for 2 s at λ295 nm and a slit 
bandwidth of 0.5 nm and blocking the excitation beam for 28 s with a beam shutter to 
avoid photobleaching of the sample. Trp emission was monitored at λ330 nm with a slit 
bandwidth of 10 nm. 
WT or mutants dissolved in PBS containing 0.05% DM or in PBS containing DDHA-PC 
liposomes were kept at 20°C for 10 min to stabilize the fluorescence emission, followed 
by 30 s illumination with a 150-watt power source equipped with a cut-off filter (λ> 495 
nm) to form Meta II. The fluorescence curve increased until it reached a plateau (Meta II 
completely decayed to opsin and free all-trans-retinal), and then fresh 11-cis-retinal was 
added and the fluorescence signal was quenched due to retinal uptake by opsin. 
Experiments were performed at least three times using independently purified samples. 
Results  
UV-Vis spectrophotometry of purified WT and mutants  
The UV-Vis spectral features of WT, G90V and N55K mutants in detergent DM solution 
are very similar to those previously reported (Figure 1).
31,32 
For all opsins, the dark-state 
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spectra showed two main characteristic bands: one at λ280nm corresponding to the opsin 
apoprotein and the other at the visible region corresponding to the retinal chromophore 
covalently bound to the protein.
35
 The λmax value of the visible chromophoric band of 
WT, G90V and N55K mutant is 499 nm, 489 nm and 495 nm respectively. In DM 
detergent, the A280/Amax ratio of WT is 1.9, whereas the ratio of G90V and N55K is 3.5 
and 6.3, respectively, being much higher than WT (Figure 1). This higher A280/Amax ratio 
could be associated with possible misfolding, aggregation or regeneration impairment of 
the mutants.  
UV-Vis spectroscopy was also used to characterize Rho behavior after illumination. 
Upon 30 s illumination, photoactived WT showed the typical shift of the visible 
absorbance band towards 380 nm (Figure 1) in DM. On the other hand, G90V and N55K 
showed an incomplete conversion of the visible band in DM,
31
 compatible with the 
formation of a photointermediate containing a protonated SB linkage.
32
 The 
photobleaching behaviour is better appreciated in the difference spectra (insets in Figure 
1). 
The WT and mutants spectra were also recorded in DDHA-PC liposomes (Figure 2). WT, 
G90V and N55K mutants were purified from COS-1 cells by transient transfection and 
inserted into DDHA-PC liposomes as described above (see Materials and Methods). In all 
cases, the λmax values in DDHA-PC liposomes are the same as those in DM detergent.
31
 
With the presence of DDHA-PC liposomes, the ratio A280/Amax of WT and mutants 
increased largely compared to DM conditions. The higher A280/Amax ratio in liposomes is 
mainly caused by the liposomes background absorption rather than an increase in protein 
misfolding or aggregation as observed in control spectra of DDHA-PC liposomes alone 
(data not shown). The photobleaching behaviour observed is similar to that in DM 
solution (Figure 2, insets). Additional electrophoretic analysis appeared to indicate 
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changes in the oligomeric status of rhodopsin in DDHA-PC liposomes (Figure 1, 
supplementary information).  
DDHA-PC liposomes increase WT and G90V thermal stability 
The thermal stability of the dark state conformations of WT and G90V and N55K mutants 
in DM and in DDHA-PC were measured at 48ºC.
31
 The thermal decay process in the dark 
is associated with retinal chromophore isomerization, hydrolysis of the protonated SB 
linkage, and eventual protein irreversible denaturation.
36,37
 The stabilizing effect of 
DDHA-PC lipids on WT can be clearly observed (Table 1 and Figure 3) (WTDM t1/2 = 
21±5, R
2
= 0.9812 and WTliposomes t1/2>500, R
2
= 0.7146) and is similar to previously 
results observed in native bovine rhodopsin.
24
 G90Vliposomes thermal stability was higher 
(t1/2 = 2.8±0.2 min; R
2
= 0.9527 ) compared to G90VDM (t1/2 = 0.7±0.1 min, R
2
= 0.9902) 
indicating that the mutant structure was protected by the DDHA-PC liposomes bilayer.
37
 
In contrast, N55Kliposomes (t1/2,= 1.8±0.1 min, R
2
= 0.9479) did not show a significant 
increase compared to N55KDM (t1/2 =1.6±0.1 min, R
2
= 0.9612) (Table 1 and Figure 3). 
The main finding is that DDHA-PC could significantly stabilize the dark conformation of 
WT and G90V mutant, whereas no significant increase in stability could be detected for 
the N55K mutant (Figure 3). This marked effect appears to be specific of the DDHA-PC 
system because experiments conducted with DMPC liposomes do not provide the same 
degree of stabilization (Figure 2, supplementary information). 
Retinal release kinetics and opsin conformational stability 
WTDM or WTliposomes, were kept in the fluorescence cuvette in the dark until Trp 
fluorescence showed a flat stable baseline. Upon illumination, Trp fluorescence signal 
started to increase, due to the retinal release from the Meta II conformation. After 
complete Meta II decay (the fluorescence curve reached a plateau), exogenous 
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11-cis-retinal was added (in a 2.5:1, retinal: opsin molar ratio) to test whether the added 
retinal could re-enter the binding pocket or not. WTDM showed no significant decrease in 
the fluorescence signal upon retinal addition after Meta II complete decay (Figure 4) 
indicating that the retinal could not enter to the opsin binding pocket. In contrast, 
WTliposomes showed an obvious decrease of fluorescence signal suggesting chromophore 
re-entry to the binding pocket thus quenching the Trp fluorescence. After Meta II 
completely decay, both G90VDM and G90Vliposomes exhibited a fluorescence signal 
decrease indicating retinal entrance into the pocket. The sector RP mutant N55K 
displayed a completely different response.
32
 Addition of exogenous retinal did not cause 
any fluorescence signal change, meaning that retinal did not enter the retinal binding 
pocket either in N55KDM or in N55Kliposomes (Figure 4).  
The t1/2 of retinal release for WT, G90V and N55K mutants in DM or DDHA-PC 
liposomes were determined (Table 1 and Figure 4). In DDHA-PC liposomes environment, 
WT, G90V and N55K presented a faster retinal release process than in DM detergent. The 
t1/2 of the retinal release process decreased from 14.3 min in DM to 4.4 min in liposomes 
for WT, from 23.4 min in DM to 15.3 min for G90Vliposomes, and from 9.5 min in DM to 
4.7 min in liposomes for N55K. 
Discussion 
DHA is present at high concentrations in the retina and in the brain. The functional role of 
this molecules has been previously investigated in the past decades.
26,38–40
 As the major 
polyunsaturated fatty acid in the rod outer segments of the photoreceptor cells, DHA level 
was associated with altered photoreceptor function in n-3 fatty acids deficient 
animals.
38,41
 It was also proposed that efficient and rapid propagation of G 
protein-coupled signaling is optimized by DHA phospholipid acyl chains.
42
 In a previous 
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study, we demonstrated the specificity of DHA in stabilizing native Rho as compared 
with other phospholipids that did not produce any stability increase.
24
 In our current study 
we used DDHA-PC to obtain liposomes to investigate the effect of this system on the 
stability and regeneration properties of Rho mutants associated with RP for the first time. 
Our main aim was to try to revert some of the conformational features (namely 
conformational instability) caused by mutations in Rho associated with the retinal 
degenerative RP disease. G90V located in helix 2, associated with classical RP, and 
N55K located in helix 1, associated with sector RP were used as prototypic mutations in 
order to study with the potential effect of DHA in vitro. 
UV-Vis spectroscopy was used to monitor the chromophore changes in WT, and G90V 
and N55K mutants upon photobleaching, and compared between DM and DDHA-PC 
liposomes conditions (Figures 1 and 2). After 30 s illumination, WT liposomes displayed a 
complete conversion of the visible band to the 380 nm absorbing species; the same 
behavior observed in DM detergent. In contrast, the mutants, but particularly 
N55Kliposomes, showed a slight partial photoconversion of the visible species to a 
photointermediate with a protonated SB linkage, when compared to DM conditions. 
We have found that DDHA-PC liposomes improve the thermal stability of Rho compared 
with DM solution. When reconstituted into DDHA-PC liposomes (Figure 3), 
G90Vliposomes increased 4-fold the thermal stability compared to G90VDM at 48ºC 
suggesting that the SB linkage was better protected from hydrolysis.
37
 Contrarily, N55K 
showed similar thermal stability both in DM and in DDHA-PC liposomes. This finding 
shows that the lipid environment does not improve the stability of the N55K mutant as 
in the case of G90V, suggesting a strong disruptive effect of the mutation for the sector 
RP N55K mutation.  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
13 
 
DDHA-PC liposomes accelerate the 11-cis-retinal release rate according to the 
fluorescence spectroscopic experiments (Figure 4). T1/2 for the retinal release process of 
WT G90V, and N55K in liposomes is faster in all cases than in DM detergent. After Meta 
II decay, the addition of exogenous 11-cis-retinal did not result in retinal uptake by WTDM, 
but allowed retinal binding to opsin in WTliposomes. G90VDM opsin showed partial ability 
to bind the 11-cis-retinal chromophore, and this ability was enhanced in G90Vliposomes 
meaning that the lipid environment facilitated the retinal uptake for this mutant. G90V, 
when compared to WT, showed a distinctive behavior, suggesting a more flexible and 
open opsin conformation already in DM whose conformational features could be 
enhanced in liposomes. Interestingly, N55K did not show any fluorescence decrease 
either in liposomes or in DM (Table 1 and Figure 4). This particular phenotype can be 
associated with a specific role of the introduced lysine,
32
 at the cytoplasmic side of TMs 1, 
2 and 7 close to this residue, that could affect retinal accessibility/release to/from the 
opsin binding pocket. In addition the reduced stability of the dark-state conformation of 
the receptor would also certainly contribute to the observed fluorescence results. This 
residue is located nearby the prospective retinal channel proposed in Rho.
43
 The 
unperturbed fluorescence spectra, upon retinal addition to N55K, suggest a lack of retinal 
binding to the N55K opsin pocket (Figure 4). This could lead to impaired receptor 
recycling causing protein aggregation and subsequent degradation. A plausible 
hypothesis is that the N55K degradation pathway would become overloaded with 
non-regenerated and aggregated N55K that would be toxic to the retinal cells being 
responsible for the sector clinical phenotype. In this regards, the particular phenotype of 
N55K has been associated with sector RP and the potential effect of light.
32
  
The neutral polyunsaturated DHA chains can play a key biological function in 
lipid-protein interactions associated with the complex process of vision. We have shown 
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that DHA increases the thermal stability of the G90V mutant but not significantly that of 
the N55K mutant, which could be consistent with the lipid-protein region of interaction 
and its specific physiological response. DHA does not appear to protect the opsin 
conformation in the case of the N55K mutant, as in the case of the classical RP G90V 
mutant and it does not facilitate retinal uptake after complete MetaII decay. This effect 
could be associated with the specific role of the lysine mutation as discussed previously.
32
 
The results obtained emphasize the distinct role of DHA on the G90V and N55K 
mutations associated with different RP phenotypes. 
The effects observed can be associated with the chemical nature of the DHA lipid. 
Different from saturated and monounsaturated hydrocarbon chains, the neutral 
polyunsaturated DHA has a unique chemical structure with six cis-locked double bounds. 
The number of freedom degrees of DHA chains is substantially lower which could be 
indicative of rigidity. Polyunsaturated chains in crystals form highly ordered, elongated 
structures with angle-iron or helical arrangement of double bonds. The experimental 
results suggest that the low order in bilayers with high DHA content is a direct 
consequence of both high conformational flexibility and rapid structural conversions of 
DHA chains themselves without significant energetic penalty.
44
 NMR data proved that 
the photointermediate Meta III had stronger contact with DHA compared with dark Rho, 
Meta I and Meta II states. DHA enrichment may enhance protein function both by a 
change of general membrane properties as well as by specific interactions with particular 
regions of the protein.
44
 N55K, located in helix 1, and G90V located in helix 2, are 
structurally located near residues 48, 50, 92, 95, 96 which are tightly packed with DHA in 
a molecular model.
45
 This specific location of the mutation sites in the Rho 
three-dimensional structure could justify the observed effects of DHA liposomes on the 
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mutants behaviour in the thermal stability and chromophore binding after 
photoactivation.  
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Table 1. Thermal Stability and Kinetics for the retinal release from the binding pocket 
of WT, and G90V and N55K mutants in PBS containing 0.05% DM or DDHA-PC 
liposomes. t1/2 (in minutes) for the thermal decay was obtained by monitoring the 
decrease of Amax when samples were incubated at 48ºC in PBS and DM or DDHA-PC 
liposomes. The t1/2 of retinal release was determined from the fluorescence curves. The 
t1/2 of retinal release clearly decreased in DDHA-PC liposomes in all cases. The t1/2 for 
the processes were determined by fitting the experimental data to single exponential 
decay curves using Sigma Plot version 11.0. All average and standard deviation were 
determined from three independent experiments. Statistical significance was determined 
by unpaired two-tailed Student’s t-test using SigmaPlot. P values < 0.05 were considered 
to be statistically significant. In our study, the differences found between DM and 
DDHA-PC were statistically significant except in the case of N55K(*) mutant thermal 
decay. 
 
 Thermal Decay (min) Retinal release (min) 
 DM 
DDHA-PC 
liposomes 
DM 
DDHA-PC 
liposomes 
WT 21±5 >500  14.3 ± 0.9 4.4 ± 0.4 
G90V 0.7±0.1 2.8±0.2  23.4 ± 0.3 15.3 ± 0.3 
N55K 1.6±0.1* 1.8±0.1* 9.5 ± 0.4 4.7 ± 0.3 
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Figure legends 
Figure 1. UV-Vis characterization of purified WT, N55K and G90V regenerated 
with 11-cis-retinal in DM. WT, and G90V and N55K mutants were expressed in COS-1 
cells and immunopurified in PBS buffer with 0.05% DM. Spectra were recorded at 20ºC. 
Illumination was carried out for 30 s with a 150 W power source equipped with an optic 
fiber guide using a λ > 495 nm cut-off filter. (—) Dark state. (····) photobleached state; 
insets, difference spectra (dark minus light). The spectra are representative of three 
independent measurements. 
Figure 2. UV-Vis characterization of purified WT, N55K and G90V regenerated 
with 11-cis-retinal in DDHA-PC liposomes. WT, and G90V and N55K mutants were 
purified and reconstituted into DDHA-PC liposomes. Spectra were recorded at 20ºC. 
Illumination was carried out for 30 s with a 150 W power source equipped with an optic 
fiber guide using a λ > 495 nm cut-off filter. (—) Dark state. (····) photobleached state; 
insets, difference spectra (dark minus light). The spectra are representative of three 
independent measurements. 
Figure 3. Thermal stability of WT, G90V and N55K mutants in PBS containing DM 
() or liposomes (o) at 48C. WT (upper panel), G90V (middle panel) and N55K (lower 
panel) mutants were purified from COS-1 cells and dissolved in PBS containing DM () 
or DDHA-PC liposomes (o). The samples were treated at 48ºC and the spectroscopic 
changes measured by means of UV-Vis spectrophotometry. All the data were recorded in 
the dark. Curves were fit to an exponential decay function. The insert of G90V and N55K 
shows the thermal decay during the first 5 minutes. WT and G90V mutant in DDHA-PC 
liposomes increases 4.2 times its thermal stability compared to the mutant in 0.05% DM. 
N55K mutant did not show any thermal decay improvement when comparing DM and 
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DDHA-PC liposomes conditions. The spectra represent the average and standard 
deviation of three independent measurements. 
Figure 4. Fluorescence spectroscopy to monitor Meta II decay and retinal uptake 
kinetics for WT and G90V, N55K mutant in PBS containing (A) DM or (B) 
DDHA-PC liposomes. Fluorescence intensity of purified WT and mutants Rho were 
stabilized at 20C in the dark and illuminated for 30 s. Upon MetaII decay and 
fluorescence stabilization, exogenous 11-cis-retinal was added. All fluorescence spectra 
were carried out by exciting the samples for 2 s at 295 nm and a slit bandwidth of 0.5 nm. 
11-cis-retinal re-enters the binding pocket in WTliposomes but not in WTDM. G90V can 
uptake the exogenous 11-cis-retinal both in DM and in DDHA-PC liposomes conditions. 
Interestingly, G90Vliposomes shows more 11-cis-retinal entry capacity. On the other hand, 
the sectorial RP mutant, N55K, remains unaltered in both conditions. The spectra are 
representative of three independent measurements. 
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Highlights 
 
● DDHA-PC liposomes stabilize the G90V rhodopsin mutation 
● The liposome system allows retinal binding only for G90V but not for N55K mutant 
● G90V conformation is likely stabilized by interaction with DHA fatty acid 
● DDHA-PC effects on rhodopsin mutants associated with different RP clinical 
phenotypes 
